These recently downgraded names are displaying both quantitative and technical deterioration.
Will the stock rally or face more downside risk?
The medical device maker had an attractive chart even before the takeover rumors.
Here's where aggressive traders could go long.
Some traders like to buy dips, but I like to buy strength.
There are several things to be encouraged about on the charts. Here's how I'd play the stock.
The stock has been in an uptrend for the past year and continues to point higher.
Now may not be the time to enter the healthcare giant's stock based on the bigger picture painted by its charts.
The shares of the provider of virtual healthcare services could stage a modest comeback based on its technical signals.
The maker of robotic products for minimally invasive surgery looks like a long play based on its technical signals.